Your browser doesn't support javascript.
loading
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma.
Zent, Clive S; Brady, Michael T; Delage, Carolyne; Strawderman, Myla; Laniewski, Nathan; Contant, Phuong N; Kanagaiah, Preshetha; Sangster, Mark Y; Barr, Paul M; Chu, Charles C; Topham, David J; Friedberg, Jonathan W.
Affiliation
  • Zent CS; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA. clive_zent@urmc.rochester.edu.
  • Brady MT; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Delage C; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Strawderman M; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Laniewski N; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Contant PN; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Kanagaiah P; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Sangster MY; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Barr PM; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Chu CC; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Topham DJ; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Friedberg JW; Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
Leukemia ; 35(6): 1788-1791, 2021 06.
Article in En | MEDLINE | ID: mdl-33128020
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Leukemia, Lymphocytic, Chronic, B-Cell / Viral Envelope Proteins / Vaccination / Waldenstrom Macroglobulinemia / Protein Kinase Inhibitors / Agammaglobulinaemia Tyrosine Kinase Type of study: Observational_studies / Prognostic_studies Limits: Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Leukemia, Lymphocytic, Chronic, B-Cell / Viral Envelope Proteins / Vaccination / Waldenstrom Macroglobulinemia / Protein Kinase Inhibitors / Agammaglobulinaemia Tyrosine Kinase Type of study: Observational_studies / Prognostic_studies Limits: Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom